[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583966":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":19,"responsibleParty":33,"collaborators":35,"id":40,"slug":10,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":10,"eligibilityCriteria":44,"healthyVolunteers":41,"sex":45,"minAge":46,"maxAge":10,"enrollmentInfo":47,"targetDuration":10,"studyType":50,"phases":10,"briefSummary":51,"conditions":52,"keywords":10,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Regina Elena Cancer Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with breast cancer who have received neoadjuvant chemotherapy or not",null,"Perform a preoperative evaluation through laboratory screening (complete blood count with reticulocyte count, iron balance, vitamin B12 and folate) and prescribe, in case of documented deficiency anemia, a therapy with hematinics. The therapy of choice in most cases of iron deficiency is parenteral ferric carboxymaltose",[13],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Giuseppina A. Natale, Doctor","CONTACT","06-52662984","+39","giuseppina.natale@ifo.it",[20],{"facility":21,"status":22,"city":23,"state":10,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":10},"\"Regina Elena\" National Cancer Institute","RECRUITING","Rome","00144","Italy","IT",{"type":28,"coordinates":29},"Point",[30,31],12.51133,41.89193,{"lat":31,"lon":30},{"type":34,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[36,38],{"name":37,"class":6},"Campus Bio-Medico University",{"name":39,"class":6},"Umberto I Hospital, Frosinone Italy","100583966",false,"NCT06883201","Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer","Inclusion Criteria:\n\n* age \\> 18 years;\n* patients diagnosed with histologically confirmed breast cancer and whether or not they have undergone neoadjuvant chemotherapy;\n* patients who are candidates for destructive and reconstructive breast surgery or not;\n* Hb values less than or equal to 11 g\u002FdL and\u002For transferrin saturation less than or equal to 20%;\n* written informed consent.\n\nExclusion Criteria:\n\n* patients with known allergies to ferric carboxymaltose or its excipients;\n* ferritin values greater than 500 ng\u002Fml;\n* patients unable to sign consent and comply with procedures.","FEMALE","18 Years",{"count":48,"type":49},78,"ESTIMATED","OBSERVATIONAL","Evaluation of the percentage of transfusions in patients with breast cancer undergoing surgery after preventive treatment with haematinics.",[53],"Breast Cancer","2025-03-12",{"date":56,"type":57},"2025-03-19","ACTUAL",{"date":59,"type":57},"2023-01-31",{"date":61,"type":49},"2025-06-30",{"name":5,"class":6},1]